Healthcare -
Biotechnology - NASDAQ - US
$ 0.84
-0.838 %
$ 65.7 M
Market Cap
5.25
P/E
CTMX - CAPITAL EXPENDITURES
Capital Expenditures CTMX - CytomX Therapeutics, Inc.
-840 K
LAST VALUE
27.75%
2 YEAR CAGR
26.01%
5 YEAR CAGR
-1.39%
10 YEAR CAGR